Detalhe da pesquisa
1.
Leucine 434 is essential for docosahexaenoic acid-induced augmentation of L-glutamate transporter current.
J Biol Chem
; 299(1): 102793, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509140
2.
Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6.
Nature
; 548(7667): 356-360, 2017 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792932
3.
Isosteric Replacement of Ester Linkage of Lysophospholipids with Heteroaromatic Rings Retains Potency and Subtype Selectivity.
Chem Pharm Bull (Tokyo)
; 71(7): 584-615, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394607
4.
Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19.
J Infect Chemother
; 27(2): 390-392, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33402301
5.
Membrane Phospholipid Analogues as Molecular Rulers to Probe the Position of the Hydrophobic Contact Point of Lysophospholipid Ligands on the Surface of G-Protein-Coupled Receptor during Membrane Approach.
Biochemistry
; 59(11): 1173-1201, 2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124599
6.
Correction: Leucine 434 is essential for docosahexaenoic acid-induced augmentation of L-glutamate transporter current.
J Biol Chem
; 299(7): 104931, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348254
7.
Non-naturally Occurring Helical Molecules Can Interfere with p53-MDM2 and p53-MDMX Protein-Protein Interactions.
Chem Pharm Bull (Tokyo)
; 67(10): 1139-1143, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582633
8.
Exploration of LPS2 agonist binding modes using the combination of a new hydrophobic scaffold and homology modeling.
Eur J Med Chem
; 252: 115271, 2023 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965226
9.
Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine.
J Med Chem
; 64(14): 10059-10101, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233115
10.
Non-naturally Occurring Regio Isomer of Lysophosphatidylserine Exhibits Potent Agonistic Activity toward G Protein-Coupled Receptors.
J Med Chem
; 63(17): 9990-10029, 2020 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32787112
11.
Probing the Hydrophobic Binding Pocket of G-Protein-Coupled Lysophosphatidylserine Receptor GPR34/LPS1 by Docking-Aided Structure-Activity Analysis.
J Med Chem
; 60(14): 6384-6399, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28715213
12.
Identification of lysophosphatidylthreonine with an aromatic fatty acid surrogate as a potent inducer of mast cell degranulation.
Biochem Biophys Rep
; 8: 346-351, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28955975
13.
Conformational Constraint of the Glycerol Moiety of Lysophosphatidylserine Affords Compounds with Receptor Subtype Selectivity.
J Med Chem
; 59(8): 3750-76, 2016 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27077565
14.
Lysophosphatidylserine analogues differentially activate three LysoPS receptors.
J Biochem
; 157(3): 151-60, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25320102
15.
Structure-activity relationships of lysophosphatidylserine analogs as agonists of G-protein-coupled receptors GPR34, P2Y10, and GPR174.
J Med Chem
; 58(10): 4204-19, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25970039